The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Aluminium Hydroxide Adjuvant Initiates Strong Antigen-Specific Th2 Responses in the Absence of IL-4- or IL-13-Mediated Signaling
Open accessAbstract
Previous studies demonstrate that aluminium hydroxide adjuvant (alum) produces increased Th1 responses in IL-4-deficient mice compared with wild-type animals, although the continued production of IL-5 by spleen cells from these mice also indicates that Th2 responses are induced. In the present study, we demonstrate that alum can induce Th2-associated IL-4 and IL-5 production in the absence of IL-4 signaling in mice deficient in either IL-4Rα or Stat6. The Th2 responses observed could not be due to IL-13 as IL-13 responses are also impaired in IL-4Rα- and Stat6-deficient mice. We also detected higher levels of IL-4 in IL-4Rα gene-deficient, though not Stat6-deficient, mice compared with their wild-type counterparts. The increased levels of IL-4 could be explained by the IL-4R being unavailable to neutralize this cytokine in IL-4Rα-deficient mice. While levels of IL-5 production in IL-4Rα- or Stat6-deficient mice were similar to IL-4-deficient and wild-type mice, other type 2-associated responses, which are largely or wholly IL-4 dependent, such as the production of IgG1 or IgE Abs, were either reduced or absent. We conclude that alum adjuvants can induce IL-4 production and Th2 responses independently of IL-4 or IL-13, negating the requirement for an early source of IL-4 in the Th2 response induced by this adjuvant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Essential role of Stat6 in IL-4 signalling
Takeda, K., Tanaka, T., Shi, W., Matsumoto, M., Minami, M., Kashiwamura, S.-I., Nakanishi, K., Yoshida, N., Kishimoto, T., & Akira, S. (1996) · Nature · doi:10.1038/380627a0 · Cited by 1,557
Lack of IL-4-induced Th2 response and IgE class switching in mice with disrupted Stat6 gene
Shimoda, K., van Deursent, J., Sangster, M. Y., Sarawar, S. R., Carson, R. T., Tripp, R. A., Chu, C., Quelle, F. W., Nosaka, T., Vignali, D. A. A., et al. (1996) · Nature · doi:10.1038/380630a0 · Cited by 1,278
IL‐4 directs the development of Th2‐like helper effectors
Swain, S. L., Weinberg, A. D., English, M., & Huston, G. (1990) · The Journal of Immunology · doi:10.4049/jimmunol.145.11.3796 · Cited by 1,254
Disruption of the murine IL-4 gene blocks Th2 cytokine responses
Kopf, M., Gros, G. L., Bachmann, M., Lamers, M. C., Bluethmann, H., & Köhler, G. (1993) · Nature · doi:10.1038/362245a0 · Cited by 1,203
Le Gros, G., Ben-Sasson, S. Z., Seder, R., Finkelman, F. D., & Paul, W. E. (1990) · The Journal of experimental medicine · doi:10.1084/jem.172.3.921 · Cited by 954
An Interleukin-4-Induced Transcription Factor: IL-4 Stat
Hou, J., Schindler, U., Henzel, W. J., Ho, T. C., Brasseur, M., & McKnight, S. L. (1994) · Science · doi:10.1126/science.8085155 · Cited by 854
Yoshimoto, T., & Paul, W. E. (1994) · The Journal of experimental medicine · doi:10.1084/jem.179.4.1285 · Cited by 841
Role of NK1.1 + T Cells in a T H 2 Response and in Immunoglobulin E Production
Yoshimoto, T., Bendelac, A., Watson, C., Hu-Li, J., & Paul, W. E. (1995) · Science · doi:10.1126/science.270.5243.1845 · Cited by 496
Hilton, D. J., Zhang, J. G., Metcalf, D., Alexander, W. S., Nicola, N. A., & Willson, T. A. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.1.497 · Cited by 401
Impaired Development of Th2 Cells in IL-13-Deficient Mice
McKenzie, G. J., Emson, C. L., Bell, S. E., Anderson, S., Fallon, P., Zurawski, G., Murray, R., Grencis, R., & McKenzie, A. N. J. (1998) · Immunity · doi:10.1016/s1074-7613(00)80625-1 · Cited by 381
Cited by
Emerging concepts in the science of vaccine adjuvants
Pulendran, B., S. Arunachalam, P., & O’Hagan, D. T. (2021) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00163-y · Cited by 1,385
Nakae, S., Komiyama, Y., Nambu, A., Sudo, K., Iwase, M., Homma, I., Sekikawa, K., Asano, M., & Iwakura, Y. (2002) · Immunity · doi:10.1016/s1074-7613(02)00391-6 · Cited by 1,052
Kool, M., Soullié, T., van Nimwegen, M., Willart, M. A. M., Muskens, F., Jung, S., Hoogsteden, H. C., Hammad, H., & Lambrecht, B. N. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071087 · Cited by 993
Towards an understanding of the adjuvant action of aluminium
Marrack, P., McKee, A. S., & Munks, M. W. (2009) · Nature Reviews Immunology · doi:10.1038/nri2510 · Cited by 887
New horizons in adjuvants for vaccine development
Reed, S. G., Bertholet, S., Coler, R. N., & Friede, M. (2009) · Trends in Immunology · doi:10.1016/j.it.2008.09.006 · Cited by 618
Carroll, E. C., Jin, L., Mori, A., Muñoz-Wolf, N., Oleszycka, E., Moran, H. B. T., Mansouri, S., McEntee, C. P., Lambe, E., Agger, E. M., et al. (2016) · Immunity · doi:10.1016/j.immuni.2016.02.004 · Cited by 596
New horizons in adjuvants for vaccine development
Reed, S. G., Tomai, M., & Gale, M. J. (2020) · Current Opinion in Immunology · doi:10.1016/j.coi.2020.08.008 · Cited by 554
Kurowska-Stolarska, M., Kewin, P., Murphy, G., Russo, R. C., Stolarski, B., Garcia, C. C., Komai-Koma, M., Pitman, N., Li, Y., McKenzie, A. N. J., et al. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.7.4780 · Cited by 460
Wilson, R. H., Whitehead, G. S., Nakano, H., Free, M. E., Kolls, J. K., & Cook, D. N. (2009) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200904-0573oc · Cited by 403
IL-33–activated dendritic cells induce an atypical TH2-type response
Rank, M. A., Kobayashi, T., Kozaki, H., Bartemes, K. R., Squillace, D. L., & Kita, H. (2009) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2009.02.026 · Cited by 399
McKee, A. S., Munks, M. W., MacLeod, M. K. L., Fleenor, C. J., Van Rooijen, N., Kappler, J. W., & Marrack, P. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0900164 · Cited by 392
Aluminium adjuvants—in retrospect and prospect
Lindblad, E. B. (2004) · Vaccine · doi:10.1016/j.vaccine.2004.03.032 · Cited by 362
Gherardi, R. K. (2001) · Brain · doi:10.1093/brain/124.9.1821 · Cited by 361
Mechanisms of stimulation of the immune response by aluminum adjuvants
HogenEsch, H. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00169-x · Cited by 354
Mechanism of action of clinically approved adjuvants
Lambrecht, B. N., Kool, M., Willart, M. A., & Hammad, H. (2009) · Current Opinion in Immunology · doi:10.1016/j.coi.2009.01.004 · Cited by 354
Akdis (2020) · doi:10.1111/pai.13189 · Cited by 320
Conrad, M. L., Ferstl, R., Teich, R., Brand, S., Blümer, N., Yildirim, A. Ö., Patrascan, C. C., Hanuszkiewicz, A., Akira, S., Wagner, H., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090845 · Cited by 320
Protein Nanoparticles: Promising Platforms for Drug Delivery Applications
Jain, A., Singh, S. K., Arya, S. K., Kundu, S. C., & Kapoor, S. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b01098 · Cited by 308
Proton-driven transformable nanovaccine for cancer immunotherapy
Gong, N., Zhang, Y., Teng, X., Wang, Y., Huo, S., Qing, G., Ni, Q., Li, X., Wang, J., Ye, X., et al. (2020) · Nature Nanotechnology · doi:10.1038/s41565-020-00782-3 · Cited by 300
Zosky, G. R., & Sly, P. D. (2007) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2007.02740.x · Cited by 298
Particulate vaccines: on the quest for optimal delivery and immune response
De Temmerman, M.-L., Rejman, J., Demeester, J., Irvine, D. J., Gander, B., & De Smedt, S. C. (2011) · Drug Discovery Today · doi:10.1016/j.drudis.2011.04.006 · Cited by 286
The role of protein digestibility and antacids on food allergy outcomes
Untersmayr, E., & Jensen-Jarolim, E. (2008) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2008.04.025 · Cited by 272
Liu, Q., Chen, X., Jia, J., Zhang, W., Yang, T., Wang, L., & Ma, G. (2015) · ACS Nano · doi:10.1021/nn5066793 · Cited by 233
“T cell response to intracellular pathogens could be characterized by differentiation of CD8þ T cells into CTLs, which killed infected cells via granzyme secretion and differentiation of CD4þ Th0 cells into CD4þ Th1 cells, which secrete cytokines such as IFN-γ.(29,30) pHresponsive PLGA NPs significantly augmented the e…”
InfluentialKinjyo, I., Inoue, H., Hamano, S., Fukuyama, S., Yoshimura, T., Koga, K., Takaki, H., Himeno, K., Takaesu, G., Kobayashi, T., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052333 · Cited by 225
Dendritic Cells: Critical Regulators of Allergic Asthma
Morianos, I., & Semitekolou, M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21217930 · Cited by 102
Schöll, I., Weissenböck, A., Förster‐Waldl, E., Untersmayr, E., Walter, F., Willheim, M., Boltz‐Nitulescu, G., Scheiner, O., Gabor, F., & Jensen‐Jarolim, E. (2004) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2004.01884.x · Cited by 95
Diesner, S. C., Knittelfelder, R., Krishnamurthy, D., Pali-Schöll, I., Gajdzik, L., Jensen-Jarolim, E., & Untersmayr, E. (2008) · Immunology Letters · doi:10.1016/j.imlet.2008.08.006 · Cited by 81
Schöll, I., Boltz-Nitulescu, G., & Jensen-Jarolim, E. (2005) · Journal of Controlled Release · doi:10.1016/j.jconrel.2004.12.020 · Cited by 51
(2013) · PubMed · Cited by 18
Metadata
- Authors
- Brewer, J. M., Conacher, M., Hunter, C. A., Mohrs, M., Brombacher, F., & Alexander, J.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-12
- Volume
- 163
- Issue
- 12
- Pages
- 6448-6454
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W2140649712
- Cited by
- 440
- References
- 30
- FWCI
- 2.99
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.